Literature DB >> 18041612

A prefrontal ERP involved in decision making during visual duration and size discrimination tasks.

Emilie Gontier1, Christophe Le Dantec, Isabelle Paul, Christian Bernard, Robert Lalonde, Mohamed Rebaï.   

Abstract

Recently, a late positive component (LPCt) with prefrontal dominance was identified in a duration discrimination task as a marker of decision-making processes (Paul et al., 2003). In the present study, LPCt amplitudes and latencies were measured in visual and size discrimination tasks for the purpose of determining the selectivity of this phenomenon. LPCt amplitudes were larger and latencies shorter for longer stimulus pairs, at a time of maximal behavioral performances. Wave amplitudes were also larger for smaller stimuli, but were not directly related to behavioral performances. These results indicate that the LPCt is not specific to temporal discrimination but can reflect more general decision-making processes.

Entities:  

Mesh:

Year:  2008        PMID: 18041612     DOI: 10.1080/00207450601046798

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  4 in total

1.  An electroencephalographic investigation of the filled-duration illusion.

Authors:  Takako Mitsudo; Caroline Gagnon; Hiroshige Takeichi; Simon Grondin
Journal:  Front Integr Neurosci       Date:  2012-01-02

Review 2.  Adapting event-related potential research paradigms for children: Considerations from research on the development of recognition memory.

Authors:  Leslie Rollins; Tracy Riggins
Journal:  Dev Psychobiol       Date:  2021-08-01       Impact factor: 2.531

3.  The Difference in Perceptual Anticipation Between Professional Tennis Athletes and Second-Grade Athletes Before Batting.

Authors:  Rong Shangguan; Yuanyuan Che
Journal:  Front Psychol       Date:  2018-08-22

4.  Post-interval EEG activity is related to task-goals in temporal discrimination.

Authors:  Fernanda Dantas Bueno; André Mascioli Cravo
Journal:  PLoS One       Date:  2021-09-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.